Obat antiretroviral: Perbedaan antara revisi

Organisasi seperti [[National Institutes of Health]] [[Amerika Serikat]] merekomendasikan penawaran perawatan antiretroviral untuk semua [[pasien]] dengan [[AIDS]], tetapi, karena kerumitan untuk memilih dan mengikuti sebuah aturan, adanya [[efek samping]], dan kepentingan untuk mencegah virus melawan perawatan ini, organisasi seperti itu menekankan kepentingan pilihan pasien yang ikut serta dalam terapi dan merekomendasikan menganalisis resikorisiko dan potensi terhadap pasien tanpa gejala.<ref name="2002nihguidelines">{{cite web | url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=12617573&dopt=Abstract | title=Guidelines for using antiretroviral agents among HIV-infected adults and adolescents | accessdate=2006-01-09 | year=[[2002-09-03]] | author=Panel on Clinical Practices for Treatment of HIV | publisher=PubMed and National Institutes of Health}}</ref>

* [http://www.aidsmeds.com/lessons/DrugChartlist.htmshtml Drug Chart]

* [http://www.aidsmeds.com/ Further drug information]

* [http://www.AIDSinfo.nih.gov/ NIH web site] {{Webarchive|url=https://web.archive.org/web/20210322035857/https://aidsinfo.nih.gov/ |date=2021-03-22 }}

* [http://www.aidsinfonyc.org/tag/tx/saquinavirten.html Ten Texts on Saquinavir] {{Webarchive|url=https://web.archive.org/web/20060214020555/http://www.aidsinfonyc.org/tag/tx/saquinavirten.html |date=2006-02-14 }}

* [http://www.retroconference.org/2000/abstracts/509.htm The Synergistic Inhibition of HIV-1 With Nucleoside Analogs Combined With A Natural Product, Resveratrol] {{Webarchive|url=https://web.archive.org/web/20060221184321/http://www.retroconference.org/2000/abstracts/509.htm |date=2006-02-21 }}

* [http://www.aidsmap.com/news/newsdisplay2.asp?newsId=2161 AZT resistance may be reversed by rheumatic drug] {{Webarchive|url=https://web.archive.org/web/20040702083640/http://www.aidsmap.com/news/newsdisplay2.asp?newsId=2161 |date=2004-07-02 }}

* [http://www.inviraseinfo.com Saquinavir Mesylate - Invirase (warning: commercial product web page)] {{Webarchive|url=https://web.archive.org/web/20170703211615/http://www.inviraseinfo.com/ |date=2017-07-03 }}

* [http://www.aegis.com/pubs/atn/1993/ATN17001.html Origins of antiretroviral combination therapy] {{Webarchive|url=https://web.archive.org/web/20040118031924/http://www.aegis.com/pubs/atn/1993/ATN17001.html |date=2004-01-18 }}

* [http://www.cptech.org/ip/health/aids/druginfo.html] Drug Patent Expiration Info

* [http://www.sciencedaily.com/releases/2007/07/070723160034.htm]

* [http://d4t.info Information on D4t , stavudine, zerit - AIDS medicine] {{Webarchive|url=https://web.archive.org/web/20071017175646/http://d4t.info/ |date=2007-10-17 }}

* [http://www.acria.org/treatment/treatment_edu_summerupdate2005.html Effects of HIV Drugs on the body] {{Webarchive|url=https://web.archive.org/web/20070929133702/http://www.acria.org/treatment/treatment_edu_summerupdate2005.html |date=2007-09-29 }}

* [http://www.thebody.com/vltest.html Viral Load] research papers, including effectiveness of HAART on reducing viral load

[[Kategori:Obat antiretroviral| ]]